Cite
MLA Citation
M. Okada et al.. “THU0248 Patient-Oriented Decision of Early Treatment of Rheumatoid Arthritis with Combination of Triple Conventional Disease Modifying Anti-Rheumatic Drugs or Tumor Necrosis Factor Inhibitors and Methotrexate (Prospective, Open-Label Clinical Trial).” Annals of the rheumatic diseases, vol. 72, 2013, p. A249. http://access.bl.uk/ark:/81055/vdc_100135538504.0x00005e